A control study of aripiprazole and tiapride treatment for tic disorders in children

Chinese Journal of Contemporary Pediatrics

Volumn 12, Issue 6, 2010, Pages 421-424

  Liu, Yan Yan ^a   Chen, Yan Hui ^a   Chen, Hui ^a   Liu, Zhi Sheng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Aripiprazole; Child; Tiapride; Tic disorders

Indexed keywords

ARIPIPRAZOLE; TIAPRIDE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIC; UNSPECIFIED SIDE EFFECT; FEMALE; MALE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; MALE; PIPERAZINES; QUINOLONES; TIAPRIDE; TIC DISORDERS;

EID: 77956632794     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kuroki T, Nagao N, Nakahara T. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis[J]. Prog Brain Res, 2008, 172: 199-212.
2. Seo WS, Sung HM, Sea HS, Bai DS. Aripiprazole treatment of children and dolescents with Tourette disorder or chronic Tic disorder[J]. J Child Adolesc Psychopharmacol, 2008, 18(2): 197-205.
3. Davies L, Stern JS, Agrawal N, Robertson MM. A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole[J]. Hum Psychopharmacol, 2006, 21(7): 447-453.
4. Miranda CM, Castiglioni TC. Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients[J]. Rev Med Chil, 2007, 135(6): 773-776.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision)[M]. Washington, DC: American Psychiatric Association, 2000: 1-943.
6. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity[J]. J Am Acad Child Adolesc Psychiatry, 1989, 28(4): 566-573.
7. Kane JM. Optimizing pharmacotherapy to maximize outcome in schizophrenia[J]. J Clin Psychiatry, 2005, 66(1): 122-133.
8. Haupt DW. Differential metabolic effects of antipsychotic treatments[J]. Eur Europsychopharmacol, 2006, 16(s3): 149-155.
9. Ben Djebara M, Worbe Y, Schupbach M, Hartmann A. Aripiprazole: A Treatment for Severe Coprolalia in "Refractory" Gilles de la Tourette Syndrome[J]. Movement Disorders, 2008, 23(3): 438-440.
10. Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, et al. Case series on the use of aripiprazole for Tourette syndrome[J]. Int J Neuropsychopharmacol, 2005, 8(3): 489-490. (Pubitemid 41002504)